CDK4 and breast carcinoma: Despite the ongoing research and development of novel cancer therapies, including cutting-edge pharmaceutical forms like engineered nanoparticles for targeted drug delivery [15], and the study of natural compounds for their potential in cancer treatment [16], the landscape of cancer care is still based on conventional therapy, such as the use of the CDK4/6i Palbo in the treatment of breast cancer.